The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    South Korea speeds up full-fledged deployment of US anti-missile battery

  • 3

    INTERVIEWHow ATEEZ achieved worldwide success

  • 5

    ANALYSISTesla, BYD's price cuts unnerve LGES, Samsung, SK

  • 7

    Actor Yoo Ah-in appears for questioning over alleged drug use

  • 9

    Apple Pay service limited by lack of NFC terminals

  • 11

    Chun Doo-hwan's grandson to apologize to victims of Gwangju massacre

  • 13

    Korean police search for 2 Kazakhstanis who fled airport

  • 15

    Samsung chief inspects production plants in China for first time in 3 years

  • 17

    Yoo Ah-in appears before police over alleged use of illegal drugs

  • 19

    Cook praises China's innovation, long history of cooperation on China visit

  • 2

    Lee Sun-kyun, Lee Ha-nee reunite in new rom-com 'Killing Romance'

  • 4

    Kakao seeks to bolster SM's global presence as new owner

  • 6

    Firstborns account for record-high 63% of newborns

  • 8

    4 young Nigerian siblings killed in house fire in Ansan

  • 10

    Foreign minister hosts Iftar dinner for Muslims in Korea

  • 12

    Busan aims to win hearts of developing nations in Expo 2030 bid

  • 14

    Bank failures and rescue test Yellen's decades of experience

  • 16

    From mines to mobility: 140-year-old partnership between Germany and Korea

  • 18

    Unrest on the Island of World Peace in 1903

  • 20

    Putin says Russia will station tactical nukes in Belarus

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
Bio
  • Tech
  • Bio
  • Companies
Tue, March 28, 2023 | 07:34
HLB's US subsidiary promotes efficacy of liver cancer drug Rivoceranib
HLB's US subsidiary promotes efficacy of liver cancer drug Rivoceranib
HLB, a global biopharmaceuticals company, said Thursday that its U.S. subsidiary Elevar Therapeutics announced the efficacy and safety of the Rivoceranib liver cancer drug at a biopharmaceutical symposium in Washington, D.C. This comes as part of the Korean biotech company's efforts to promote the drug ahead of applying for new drug application (NDA) with the U.S. Food and Dr...
Baek Byung-yeul | 2023-03-23 16:24
POSCO International to expand carbon capture biz in green energy push
POSCO International to expand carbon capture biz in green energy push
POSCO International said Tuesday it will nurture carbon capture and storage (CCS) as one of its future growth drivers as the trading company accelerates its expansion into green energy.
2023-03-21 11:32
Samsung Biologics seeks to expand partnerships in New York
Samsung Biologics seeks to expand partnerships in New York
Samsung Biologics will take part in 2023 DCAT Week, a global event in the bio and pharmaceutical industry, which will take place in New York from March 20 to 23, in a bid to seek more partnerships, the company said Thursday. Hosted by the Drug, Chemical & Associated Technologies Association (DCAT), DCAT Week has been a representative networking event in the pharmaceutical ind...
Baek Byung-yeul | 2023-03-16 16:05
Celltrion founder to return to management after 2 year-hiatus
Celltrion founder to return to management after 2 year-hiatus
Seo Jung-jin, founder and honorary chairman of Celltrion, may return to management after two years, on expectations he can save the biotechnology group that is facing growing business uncertainties, according to company officials, Friday.
Baek Byung-yeul | 2023-03-03 16:52
Kakao Healthcare to launch blood sugar managing app in Q3
Kakao Healthcare to launch blood sugar managing app in Q3
Kakao Healthcare, a subsidiary of internet company Kakao, revealed a detailed vision for digital healthcare, saying it will launch a blood sugar management app in the third quarter of this year, according to the CEO, Thursday. “Digital healthcare has emerged as a lucrative business,” Hwang Hee, CEO of Kakao Healthcare, said during a press conference at Kakao's building in Seo...
Baek Byung-yeul | 2023-03-02 16:22
Samsung Biologics hit by series of attempts to steal trade secrets
Samsung Biologics hit by series of attempts to steal trade secrets
Samsung Biologics has been grappling with a series of attempts to steal its trade secrets as competition is intensifying in contract-based drug development and manufacturing, according to police and industry officials, Monday. Incheon Metropolitan Police said one of Samsung Biologics' employees was arrested recently for attempting to take company data from a worksite without ...
Baek Byung-yeul | 2023-02-27 16:56
Will Medytox's legal win over Daewoong deal blow to Hugel?
Will Medytox's legal win over Daewoong deal blow to Hugel?
Medytox's legal win over Daewoong Pharmaceutical is expected to shake up the local botulinum toxin (BTX) market, as Medytox, Korea's first Botox developer, is also embroiled in a legal tussle with another competitor, Hugel in the United States, over the BTX strain used to manufacture the cosmetics treatment, according to the companies, Monday. On Friday, the Seoul District Co...
Baek Byung-yeul | 2023-02-13 16:45
Medytox wins botulinum toxin patent suit against Daewoong
Medytox wins botulinum toxin patent suit against Daewoong
Medytox won a lawsuit against Daewoong Pharmaceutical on Friday over a botulinum toxin (BTX or Botox) patent. The two companies had locked horns over the origin of BTX strain used to manufacture the cosmetic treatment. “Daewoong Pharmaceutical's Nabota was developed by stealing Medytox's botulinum toxin strains and manufacturing process,” the Seoul Central District Court said...
Baek Byung-yeul | 2023-02-12 16:29
HLB's anticancer drug wins approval in China
HLB's anticancer drug wins approval in China
HLB's anticancer drug Rivoceranib was approved to be used for first-line treatment for liver cancer in China, the Korean biotech company said Thursday. The company said China's National Medical Products Administration (NMPA) approved the combination therapy of Rivoceranib and Camrelizumab, an anticancer drug of China's Jiangsu Hengrui Medicine, as a first-line treatment for l...
Baek Byung-yeul | 2023-02-02 16:44
SK Bioscience recruits experts for global expansion
SK Bioscience recruits experts for global expansion
SK Bioscience, developer of SKYCovione, Korea's first COVID-19 vaccine, has recruited renowned executives who have worked for global biopharmaceutical companies as part of its efforts to advance into the global market and diversify, according to the company, Friday. The company said it appointed Richard Kensinger as vice president of R&D project management at its U.S. branch,...
Baek Byung-yeul | 2023-01-20 14:40
 1 2345678
Top 10 Stories
1[ANALYSIS] Tesla, BYD's price cuts unnerve LGES, Samsung, SK ANALYSISTesla, BYD's price cuts unnerve LGES, Samsung, SK
2Yoo Ah-in appears before police over alleged use of illegal drugs Yoo Ah-in appears before police over alleged use of illegal drugs
3US aircraft carrier to visit Busan amid NK provocations US aircraft carrier to visit Busan amid NK provocations
4Families of foreign construction workers can receive retirement pay: court Families of foreign construction workers can receive retirement pay: court
5Indonesian investment minister promotes EV cooperation with Korea Indonesian investment minister promotes EV cooperation with Korea
6Nongshim plans to build plant in eastern US region Nongshim plans to build plant in eastern US region
7Korean crypto investors want Do Kwon punished in USKorean crypto investors want Do Kwon punished in US
8Gimpo-China flights recover to pre-pandemic levels Gimpo-China flights recover to pre-pandemic levels
9Right-wing Japanese support Seoul-Tokyo ties: Korean envoy to JapanRight-wing Japanese support Seoul-Tokyo ties: Korean envoy to Japan
10Local bank stocks hit by shockwaves from SVB, CS collapses Local bank stocks hit by shockwaves from SVB, CS collapses
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group